# Hepatic Artery Infusion Pump for NPC Liver Metastases

> **NCT03876574** · PHASE1 · COMPLETED · sponsor: **Xiangya Hospital of Central South University** · enrollment: 16 (actual)

## Conditions studied

- Nasopharyngeal Carcinoma
- Neoplasm Metastasis
- Liver

## Interventions

- **PROCEDURE:** DSA-guided implantation of hepatic artery infusion pump
- **DRUG:** Gemcitabine
- **DRUG:** Floxuridine
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT03876574
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2017-12-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-03-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03876574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03876574, "Hepatic Artery Infusion Pump for NPC Liver Metastases". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03876574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*